2.Effects of Stress Response to Surgical Procedures upon Secretion of Salivary Immunoglobulin A in Mice
Nobuyuki Y. Watanabe ; Yoichi Nakagawa ; Satonari Akutsu ; Akira Yamane
Oral Science International 2005;2(2):96-103
Secretory immunoglobulin A (sIgA) plays an important role in mucosal immunity, and salivary levels change in response to social, psychological and physical stress. However, little is understood about how surgical stress affects salivary sIgA. The results of the present study showed that mouse salivary IgA concentration was significantly elevated immediately after surgery and returned to pre-surgical levels after 24 h. Thus, the surgery did not suppress IgA secretion under our experimental conditions, suggesting that mucosal immunity was not perturbed. Since the role of α-adrenergic receptors involved in IgA secretion has remained unclear under surgical stress, we further examined the effects of either α1-adrenergic (prazosin) or α2-adrenergic antagonist (yohimbine) on the salivary sIgA. Yohimbine, but not prazosin, antagonized the surgically induced salivary IgA enhancement, indicating mediation by α2-receptor stimulation. The mRNA for IgA was not altered in the salivary gland after surgery, suggesting that surgical stress did not stimulate IgA synthesis in the salivary gland cells. In conclusion, it is suggested that the surgical stress does not perturb mucosal immunity in our experimental model, although a transient increase of concentration of salivary IgA was observed immediately after surgical insult.
3.The Study and the Clinical Trial on “Yakumi” and “Yakusei” of “Dokakonsan” in “Women's Disease of Kinki Yoryaku”
Takeshi WATANABE ; Yoshiyuki URATSUJI ; Tatsuhiko HORI ; Yoichi MORITA
Kampo Medicine 1984;35(4):255-272
“DOKAKONSAN IN KINKI YORYAKU” in the original is limited to the usage of women whose menses recur twice a month and of men whose genitals are swollen and painful.
Judging from “YAKUSEI and YAKUNO” of four kinds of ingredients, we recognize the herb is effective against the syndrome, “KEISHITOSHO” easily caught by the Japanese, accompanyed with “KETSUNETSU” and “CHINKYU-OKETSU”.
We got remarkably effective results, after we made the chart of the symptoms at a radorgraph from the point of view of “KOHO” (the ancient school), “HOSHO-ITCHI”, on the basis of six factors, “KI”, “KETSU”, “SUI”, “HI-I”, and “KAN and NETSU”, and administered the herb for 50 cases equivalent to the factors by “TANPO” (a single dose), “KAHO”, or “GAPPO”.
The herb is administered to a broad range, that is, both sex from infants to the aged.
The indications are firstly musculus skeleti connective tissue symptoms and each field of symptoms excluding sensorial symptoms and blood dyscrasia.
Observing the process that “KESSHO” is changed into “KANKETSU” through “OKETSU” and the medicine, “KUOKETSU-ZAI”, the removal medicine, “DOKAKONSAN” can be a unique herb to be effective against the begining stage of “KANKETSU” and to be “ZANRYU-OKETSU KAIJYOZAI” after the administration of “KANKETSU CHINKYU OKETSUZAI”.
4.Risk Factors for Excessive Sensitivity to Cold and Physical Characteristics:A Prospective Cohort Study
Yoichi FURUYA ; Tetsuo WATANABE ; Yutaka NAGATA ; Ryosuke OBI ; Hiroaki HIKIAMI ; Yutaka SHIMADA
Kampo Medicine 2011;62(5):609-614
PURPOSE : To determine risk factors for excessive sensitivity to cold (ESC) in relation to physical features.DESIGN : A prospective cohort study carried out between July 7 and November 14,2008.PARTICIPANTS AND METHODS : Seventy female junior college students with no ESC at baseline, and a median age of 20 years, participated. We used a numerical rating scale (NRS) to classify each ESC sensation over the five days in this July-November period.To confirm physical symptoms, we used Terasawa's diagnostic scores for ki, ketsu, and sui. We defined ESC as mean NRSgeq ≥ 5.RESULTS : We documented 17 participants with ESC in November. The multivariate adjusted odds ratio for ESC was11.6 (95% CI 1.9 to 97.5) for the physical characteristic “edema”. Participants with ESC were shorter in stature than participants without ESC (-5.9cm ; 95% CI -8.6 to -3.1).CONCLUSION : Participants with edema and short stature have a high risk for ESC.
5.Use of the Prognostic Nutritional Index to predict clinical outcomes of patients with terminal stage cancer
Yoichi Nakamura ; Jiro Nagao ; Yoshihisa Saida ; Manabu Watanabe ; Yasushi Okamoto ; Koji Asai ; Toshiyuki Enomoto ; Takaharu Kiribayashi ; Shinya Kusachi
Palliative Care Research 2013;8(2):199-202
Introduction: The importance of estimating the prognosis of advanced cancer patients is well known, but clinicians do not estimate survival time accurately. Since there is a need for an objective index to estimate survival time, the utility of the Prognostic Nutritional Index (PNI), which depends only on objective factors, was evaluated. Methods: The PNI was calculated using the following formula, PNI=10×serum albumin value (g/dL)+0.005×lymphocyte count in peripheral blood, at 3 months, 2 months, 1 month, 3 weeks, 2 weeks, 1 week, and within 3 days before death in 278 cancer patients (166 men, 112 women; age range, 33-99 years; mean age, 69.8 years) who died in a hospital surgical unit. Results: Sites of primary diseases included lung, breast, esophagus, stomach, colorectum, liver, biliary tract, and pancreas. The PNI values showed a gradual decrease over time. Changes in the PNI values were lower in non-gastrointestinal cancer patients than in gastrointestinal cancer patients. The mean PNI value was significantly higher in patients who lived >3 weeks (38.8) than in those who died within 3 weeks (32.4). When the PNI cut-off point was set at 35, and it was assumed that the life expectancy was within 3 weeks in cases with PNI <35, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 74.8%, 62.2%, 68.1%, and 69.6%, respectively. Discussion: The PNI appears to be a useful and simple parameter to predict clinical outcomes of patients with terminal stage cancer. Particularly, the PNI is considered feasible for gastrointestinal cancer patients.
6.Acute Thrombosis of Abdominal Aortic Aneurysm: Case Report.
Tsuguo IGARI ; Fumio IWAYA ; Kenichi HAGIWARA ; Masahiro TANJI ; Hirono SATOKAWA ; Masaaki WATANABE ; Hirofumi MIDORIKAWA ; Yoichi SATOU ; Takashi ONO ; Shunichi HOSHINO
Japanese Journal of Cardiovascular Surgery 1992;21(1):104-107
In a consecutive series of 160 surgically treated abdominal aortic aneurysm, four patients with acute aortic thrombotic occlusion of an abdominal aortic or iliac aneurysm were encountered. Three of four aneurysms were 7cm in diameter or smaller. Also, 3 of 4 patients had chronic occlusive disease of legs. Our mortality rate was 75%. The recommendation is made that all abdominal aortic aneurysms be resected if there is substantial associated distal occlusive disease.
7.The Effect of Nafamostat Mesilate for the Treatment of Disseminated Intravascular Coagulation after Surgery Using Cardiopulmonary Bypass.
Hirono Satokawa ; Fumio Iwaya ; Tsuguo Igari ; Kenichi Hagiwara ; Masahiro Tanji ; Masaaki Watanabe ; Hirohumi Midorikawa ; Yoichi Sato ; Shinya Takase ; Shunichi Hoshino
Japanese Journal of Cardiovascular Surgery 1994;23(1):33-37
To investigate the effect of nafamostat mesilate (FUT) for disseminated intravascular coagulation (DIC) after surgery using cardiopulmonary bypass, we studied DIC scores and parameters of coagulation and fibrinolysis in the DIC cases. Although 12 patients developed DIC, the platelet counts improved by administration of FUT apart from one complicated by sepsis. The DIC scores decreased as a result of the increase of platelets and fibrinogen and improvement of FDP. Thrombin-antithrombin III complex, D-dimer and plasmin-α2 plasmin inhibitor complex showed an even higher value at the endpoint of FUT administration. These results indicate that patients with DIC after cardiopulmonary bypass may have severe fibrinolytic acceleration and that administration of FUT can be useful in those cases.
8.Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab.
Yuichiro OHSHIMA ; Yumi KINOSHITA ; Yoichi AKITA ; Yasuhiko TAMADA ; Daisuke WATANABE
Annals of Dermatology 2013;25(4):496-497
No abstract available.
Antibodies, Monoclonal
;
Antibodies, Monoclonal, Humanized
;
Arthritis, Psoriatic*
;
Adalimumab
;
Infliximab
9.Evaluation of Trunk Stability in the Sitting Position Using a New Device
Kimio Saito ; Yoichi Shimada ; Naohisa Miyakoshi ; Toshiki Matsunaga ; Takehiro Iwami ; Michio Hongo ; Yuji Kasukawa ; Hidetomo Saito ; Norimitsu Masutani ; Yasuhiro Takahashi ; Satoaki Chida ; Kazutoshi Hatakeyama ; Motoyuki Watanabe ; Junki Ishikawa ; Yusuke Takahashi ; Masamichi Suzuki ; Shu Murata
The Japanese Journal of Rehabilitation Medicine 2017;54(1):31-35
10.Treatment of Intractable Pneumothorax with Emphysema Using Endobronchial Watanabe Spigots.
Doo Yun LEE ; Yu Rim SHIN ; Jee Won SUH ; Seok Jin HAAM ; Yoon Soo CHANG ; Yoichi WATANABE
The Korean Journal of Thoracic and Cardiovascular Surgery 2013;46(3):226-229
Prolonged air leakage is a major cause of morbidity in pneumothorax. When conservative management is not effective, surgery should be performed. However, surgery is not appropriate in patients with low pulmonary function. In these patients, occlusion of the airway with endobronchial blockers may be attempted under bronchoscopy. We treated two patients with prolonged air leakage using endobronchial Watanabe spigots under fibrobronchoscopy.
Bronchoscopy
;
Emphysema
;
Endoscopy
;
Humans
;
Pneumothorax
;
Pulmonary Emphysema